X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 51,703 | 29,085 | 22,247 | 24,346 | 14,825 |
| Operating Income | -51,703 | -29,085 | -22,247 | -24,346 | -14,825 |
| Interest Expense | 2,147 | 720 | 490 | 2,515 | 472 |
| Other Income | 1,043 | -3,480 | 743 | 3,886 | 2,079 |
| Pre-tax Income | -52,807 | -33,285 | -21,994 | -22,975 | -13,218 |
| Net Income Continuous | -52,807 | -33,285 | -21,994 | -22,975 | -13,218 |
| Net Income | $-52,807 | $-33,285 | $-21,994 | $-22,975 | $-13,218 |
| EPS Basic Total Ops | -139.04 | -2,376.88 | -1,639.04 | -8,068.66 | -4,687.35 |
| EPS Basic Continuous Ops | -137.54 | -2,177.67 | -1,442.10 | -8,059.58 | -4,681.22 |
| EPS Diluted Total Ops | -139.04 | -2,376.88 | -1,639.04 | -8,068.66 | -4,687.35 |
| EPS Diluted Continuous Ops | -137.54 | -2,177.67 | -1,442.10 | -8,059.58 | -4,681.22 |
| EPS Diluted Before Non-Recurring Items | -139.04 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-51,600 | $-28,982 | $-22,176 | $-24,061 | $-14,436 |